Palantir Makes a Move - Now Look At the Chart
One under-the-radar company just partnered with Palantir to take autonomous security to the next level.
| Open | 27.32 | Prev Close | 27.32 |
| High | 27.32 | Low | 27.32 |
| Volume | 0 | Volume (Avg) | 1,761 |
| 52 Week High | 60.37 | 52 Week Low | 25.81 |
| Market Cap | 2.6B | PE Ratio |
General
| Name | Ultragenyx Pharmaceutical Inc |
| Ticker | RARE |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Currency | USD |
| Country | USA |
| Fiscal Year End | December |
| Full Time Employees | 1,294 |
About Ultragenyx Pharmaceutical Inc
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Latin America, Europe, the Middle East, Africa, and the Asia-Pacific. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast growth factor 23 for the treatment of X-linked hypophosphatemia, as well as tumor-induced osteomalacia; Mepsevii, an enzyme replacement therapy for the treatment of children and adults with Mucopolysaccharidosis VII; Dojolvi for the treatment of long-chain fatty acid oxidation disorders; and Evkeeza (evinacumab) for the treatment of homozygous familial hypercholesterolemia. The company's products candidates that are in Phase 3 clinical trials include UX143, a human monoclonal antibody for the treatment of osteogenesis imperfecta; UX111, an AAV9 gene therapy product candidate for the treatment of patients with Sanfilippo syndrome type A, or MPS IIIA, a rare lysosomal storage disease; DTX401, an adeno-associated virus 8 (AAV8) gene therapy clinical candidate for the treatment of patients with glycogen storage disease type Ia; DTX301, an AAV8 gene therapy for the treatment of patients with ornithine transcarbamylase; and GTX-102, an antisense oligonucleotide for the treatment of Angelman syndrome. It also develops UX701 that is in Phase 2 clinical trial for the treatment of Wilson disease; and UX053 for the treatment of glycogen storage disease type III. Ultragenyx Pharmaceutical Inc. has collaboration and license agreement with Kyowa Kirin Co., Ltd.; Saint Louis University; Baylor Research Institute; REGENXBIO Inc.; GeneTx; Mereo; University of Pennsylvania; Solid Biosciences Inc.; Regeneron; Abeona; and Arcturus Therapeutics Holdings Inc. The company was incorporated in 2010 and is headquartered in Novato, California.
Highlights
| Analyst Target | 84.60 |
| Market Cap | 2,582,900,000 |
| PEG Ratio | -0.24 |
| EBITDA | -477,876,992 |
Valuation
| Price/Sales (Trailing 12 Mt.) | 4.37 |
| Price/Book (Most Recent Quarter) | 17.79 |
Technicals
| Beta | 0.24 |
| 52 Week High | 60.37 |
| 52 Week Low | 25.81 |
| 50 Day Average | -19.81% |
| 200 Day Average | -32.98% |
Earnings
Trump Says 5 Jets Downed During India-Pakistan Conflict: '...Shot Out Of The Air'
President Donald Trump during a dinner with Republican lawmakers stated, that up to 5 jets were shot down during the India-Pakistan conflict.
Why Is Donald Trump Ignoring Elon Musk's Call For 'Phase 2' Of The Epstein Files?
Musk's post questioning Trump's unfulfilled promise of Epstein-related disclosures reignites tensions over transparency in politics and tech.
Back the Biotech Company Unlocking Mushroom Health Benefits for All - Ad
Functional mushrooms can boost mental, gut, and immune health-but people can't grow them at home. One company is making it easy with a patent-pending kitchen device. Think Nespresso, but for mushrooms. The functional mushroom market is projected to nearly double by 2030.
Rigetti Computing, Netflix, Johnson & Johnson, United Airlines And ASML: Why These 5 Stocks Are On Investors' Radars Today
U.S. stocks moved higher today, with the Dow Jones gaining more than 200 points, or 0.5%, to close at 44,254.78.
Cathie Wood Doubles Down On Tesla Despite Leadership Exodus, Dumps $22 Million Of Crypto Stocks Amid Bitcoin Buzz
Cathie Wood-led Ark Invest made significant trades on Tuesday, involving major companies like Tesla Inc. (NASDAQ:TSLA), Coinbase Global Inc.
How to Hack a $1.3T Market - Ad
Forget concrete. The new foundation for real estate success is digital, and Pacaso leads the way. Their tech unlocks a $1.3T real estate market. They've already earned $110M+ in gross profits in their operating history and reserved the Nasdaq ticker PCSO.
After years of tough rules on liquids and footwear, US air travel may be on the cusp of a new era
NEW YORK (AP) — When limits on liquids were introduced at TSA checkpoints across the country in 2006, bins overflowed with bottled water, toothpaste, shaving cream and so much more. Nearly two decades later, travelers are much more accustomed to the “3-1-1” regulations" governing the size of the liquids they're flying with, but scenes of passengers guzzling a beverage before putting their bags through the screening machines are still common.
Russia insists on achieving Ukraine goals despite Trump's ultimatum
Russia is open to peace with Ukraine, but achieving its goals remains a priority, Kremlin spokesman Dmitry Peskov said Sunday, days after U.S. President to agree to a ceasefire or .
Palantir's AI Is Going Physical - Ad
The next wave of security AI is happening now. Palantir just joined forces with a company already doing the work.
Tesla Cybertruck Bet Not Paying Off? Ford, GM Outsell EV Giant
Elon Musk's dream of having a top-selling electric pickup may be a thing of the past as the Cybertruck continues to see declining demand.
ASML Stock Plunges Nearly 8% In Wednesday Pre-Market: What's Going On?
Shares of Dutch semiconductor firm, ASML Holding NV (NASDAQ: ASML), has declined 7.46% during Wednesday pre-market trading, after the company expressed concerns over its 2026 growth prospects.
If You Missed Tesla, Here's Your "Second Chance"... - Ad
If you missed your shot at turning $1,000 into more than $18,000 when I recommended Tesla, you'll want to pay close attention. I'm 100% convinced Elon's "Agenda X" could make early investors rich. But you need to hurry, because Elon and Visa are moments away from launching.
Carney Faces Cross-Border Pressure Amid High-Stakes US Trade Talks
Carney faces growing criticism at home as Trump threatens steep tariffs amid tense Canada-U.S. trade negotiations.
One Tech Tip: How to clean your computer, earbuds and smartphone
LONDON (AP) — Smartphones, laptops, headphones and other electronic devices are essential for work and play in our daily lives. But all that time spent typing, scrolling or listening also means our devices gradually accumulate grime that needs to be cleaned off.
Back This Medical AI Tech - Ad
You don't often find healthcare tech company valued at $4M. HeartSciences is an exception. With $75M invested, including R&D, clinical trials, and product development, their patented AI software is approaching FDA submission, a potential major inflection point.
Elon Musk Changed His Number, Became Unreachable After Trump Feud, Reveals Speaker Mike Johnson: 'I Sent Him A Long Text Message, And Then...'
Tesla Inc. (NASDAQ: TSLA) CEO Elon Musk has reportedly changed his phone number following a fued with President Donald Trump and disagreement with Speaker Mike Johnson over the Republican's tax-and-spending bill.
Nvidia-Supplier Taiwan Semiconductor On A Roll, Profit Explodes With Strong Margin Growth
Taiwan Semiconductor (TSM) reports strong Q2 results and expects continued growth in demand for advanced processor technologies, with revenue guidance of $31.8 billion to $33.0 billion for Q3.
FDA Submission Expected This Summer - Invest Before It Happens - Ad
This company is making heart disease easier to detect with AI. Their tech has officially been designated a "Breakthrough" by the FDA. You now have an opportunity to get in at a potential inflection point.
1.4M of the nation's poorest renters risk losing their homes with Trump's proposed HUD time limit
WOODINVILLE, Wash. (AP) — Havalah Hopkins rarely says no to the chain restaurant catering gigs that send her out to Seattle-area events — from church potlucks to office lunches and graduation parties.
Japanese leader Ishiba vows to remain despite speculation, says he will focus on new US trade deal
TOKYO (AP) — Prime Minister on Wednesday vowed to remain in power to oversee the implementation of a , despite media speculation and growing calls for him to resign after a .
Tap Into the $65B 'Shroom Boom' - Ad
People are rapidly discovering how mushrooms can enhance brain function, gut health, immunity, and more. The only thing holding them back? A simple way to grow them. Hypha Labs built a compact countertop device to solve exactly that.
Business News Digest
AP Business Digest
Retirees, here’s how to tweak the 4% rule to protect your nest egg
New retirees might enter a different environment than their predecessors—the economy or market might have changed slightly or dramatically.
Investing Legend Hints the End May Be Near for These 3 Iconic Stocks - Ad
Futurist Eric Fry say Amazon, Tesla and Nvidia are all on the verge of major disruption. To help protect anyone with money invested in them, he's sharing three exciting stocks to replace them with. He gives away the names and tickers completely free in his brand-new "Sell This, Buy That" broadcast.
Leaders of the UK and Germany to sign a treaty on defense, trade and migration
LONDON (AP) — and are set to sign a treaty on Thursday pledging to tighten defense ties and step up law-enforcement cooperation against gangs that smuggle migrants .
Kohl's Corp, Krispy Kreme, Lockheed Martin, Circle Internet And Lucid Group: Why These 5 Stocks Are On Investors' Radars Today
The U.S. stock market experienced a mixed session today. The Nasdaq fell nearly 80 points, closing down 0.4% at 20,892.69
Is Elon's Empire Crumbling? - Ad
Jeff Brown - the legend who called Tesla and Nvidia early - says Elon is about to launch a $25T AI revolution. This isn't another chatbot. It's real-world AI that could 14X the impact of ChatGPT. But after October 23rd, it may be too late.
Gene Munster Says AI Risk Is 'Still On The Table' For Google Despite Blowout Q2 Earnings, But Admits Search Was 'Strong' For Alphabet: 'Investors Will Likely Come Back'
Gene Munster praised Google Search as "rock solid" following Alphabet's blowout Q2 earnings, but cautioned that AI disruption still poses a long-term risk to the company's future dominance.
General Motors profit and revenue drops, but it maintains lowered full year outlook
General Motors’ profit and revenue declined in its second-quarter but the automaker easily topped expectations and the company stuck by its full-year financial .
Palantir Makes a Move - Now Look At the Chart - Ad
One under-the-radar company just partnered with Palantir to take autonomous security to the next level.
Trump-Backed Crypto Bills Stalled Again In House Of Representatives, Marjorie Taylor Greene Holds Out On CBDC Ban: 'Will Not Vote For This'
House Republican leaders faced another setback Wednesday in their efforts to move key cryptocurrency bills, due to disagreements among GOP lawmakers.
Lin-Manuel Miranda will turn 'Hamilton' 10th anniversary into a fundraiser for immigration services
plans to use the Broadway performance of his award-winning cultural phenomenon as a fundraiser for a coalition of nonprofits providing immigration services.
Back the Biotech Company Unlocking Mushroom Health Benefits for All - Ad
Functional mushrooms can boost mental, gut, and immune health-but people can't grow them at home. One company is making it easy with a patent-pending kitchen device. Think Nespresso, but for mushrooms. The functional mushroom market is projected to nearly double by 2030.
Robert Kiyosaki Says ETFs Are Like Pictures of Guns, Real Assets Are Better
Robert Kiyosaki recently shared his views on ETFs on X, comparing them to "pictures of guns" and advocating for real assets.
Scott Bessant Eyes 'Big, Beautiful Rebalancing' With China — Says Beijing Must Shift Toward Consumption, Teases 'Very Interesting' Purchase Agreements
U.S. Treasury Secretary Scott Bessent says that the United States and China are entering a more constructive phase in trade talks.
How to Hack a $1.3T Market - Ad
Forget concrete. The new foundation for real estate success is digital, and Pacaso leads the way. Their tech unlocks a $1.3T real estate market. They've already earned $110M+ in gross profits in their operating history and reserved the Nasdaq ticker PCSO.
Whistleblower's Texts Allege Ex-Trump Lawyer Bove Encouraged Lawbreaking. Now He's Up for a Judgeship.
Emil Bove is on the verge of a lifetime appointment as a judge, despite allegations of professional misconduct.
'Insiders Have Rarely Been This Bearish': Selling Spree By Executives Sweeps Across S&P 500, But There Is One Sector Bucking The Trend
Sentiment among corporate insiders has plunged to an unprecedented low, as evidenced by the substantial insider selling activity seen in recent months.
Palantir's AI Is Going Physical - Ad
The next wave of security AI is happening now. Palantir just joined forces with a company already doing the work.
Female HR exec caught on Coldplay cam resigns after embrace with CEO went viral
The female executive who was caught on camera embracing the CEO of her company at a Coldplay concert in a moment that went viral has resigned, according to news reports.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.